CClinicalTrials.gg
CompletedNCT06491641Updated Jul 29, 2025

The Effect of Nursing Care Based on Kolcaba's Comfort Theory on the Newborn

An interventional study of Care based on Kolcaba's comfort theory in Pain, Comfort Theory and Hemodynamic Variables, sponsored by Cukurova University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 1 Hour to 28 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-29.

Sponsored by Cukurova University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
1 Hour to 28 Days
Sex
All
01

Study summary

It was planned to determine the effect of nursing care based on Kolcaba's Comfort Theory on newborns' comfort, pain and hemodynamic variables for babies admitted to the neonatal intensive care unit.

  • Does nursing care based on comfort theory reduce the comfort and pain levels of newborn babies?
  • Does nursing care based on comfort theory have an effect on babies' vital signs?
Read the detailed description

Comfort is defined as "an expected result with a complex structure within the physical, psychological, social and environmental integrity of helping the individual with his/her needs, providing peace of mind and being able to overcome problems." In his theory, Kolcaba defined comfort as "an expected result with a complex structure within the physical, psychospiritual, social and environmental integrity of helping the individual with his needs, providing peace of mind and overcoming problems."

The concept of comfort has been frequently used in neonatal intensive care units (NICU) and newborn babies in recent years. Unlike intrauterine life, NICU is an environment for newborn babies where there is noisy, cool, bright, dry, heat and light conditions are not good, and the baby has difficulty in making movements due to the power of gravity.

The physical structure of intensive care units (NICU), the anatomical and physiological immaturity of newborn babies, frequent routine care and invasive procedures may cause babies to lose their comfort.

This situation affects recovery and discharge times. Studies indicate that comfort is one of the most important factors affecting the speed of recovery.

The sample size of the study was determined using power analysis. The power of the research is defined as the possibility of revealing the difference between two applications. A study must have at least 80% power. It was calculated using the G. Power-3.1.9.4 program at the study's reliability coefficient of α=0.05 and 85% confidence level. In their study titled "The effect of the comfort care model on distress, pain and hemodynamic parameters in infants after congenital heart defect surgery", they found the effect size to be 0.816 and the minimum sample size to be 0.816. intervention with a theoretical power of 0.85. A total of 56 individuals will be included, 28 in the control group and 28 in the control group. Considering data loss, the study will be conducted with a total of 60 newborns, 30 newborns in each group.

02

Conditions studied

  • Pain
  • Comfort Theory
  • Hemodynamic Variables

Browse trials for

Keywords

  • pain
  • Comfort
  • Hemodynamic Variables
  • Kolcaba's Comfort Theory
03

In context

Pain

2,219 studies on the registry are indexed under Pain; 917 are open to participants now.

This study's enrollment of 62 is below the median of 70 across 1,904 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Cukurova University is the lead sponsor of 247 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Hour to 28 Days
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Newborns with suspected or diagnosed sepsis
  • Avoiding the use of analgesic, sedative or muscle relaxant drugs that may affect comfort.
  • No congenital anomalies,
  • Birth weight over 1500 grams,
  • No need for mechanical ventilation,
  • Vital signs are stable,
  • Hospitalization of babies in the first 48 hours after birth,
  • Newborn babies whose babies are deemed stable by the neonatologist will be included in the study.
  • No hyperbilirubinemia requiring exchange transfusion,
  • Those who do not have intrauterine infection (rubella, syphilis, toxoplasma) will be included in the study.

Exclusion criteria

Exclusion Criteria:

  • Newborns with sepsis or suspected sepsis
  • Analgesic, sedative or muscle relaxant medication that may affect comfort is given,
  • Enteral-fed infants,
  • Having a congenital anomaly,
  • Birth weight below 1500 grams,
  • Those who require mechanical ventilation,
  • Vital signs are unstable,
  • Babies who are not hospitalized in the first 48 hours after birth,
  • Newborn babies whose babies are not deemed stable by the neonatologist will not be included in the study.
  • Those with hyperbilirubinemia requiring exchange transfusion,
  • Those with intrauterine infection (rubella, syphilis, toxoplasma) will not be included in the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
62 participants (actual)

Study arms

  • Experimental
    Experimental Group

    During the application process, the babies in the experimental group will receive care based on Kolcaba's comfort theory during their stay in intensive care.

    Other: Care based on Kolcaba's comfort theory

  • No intervention
    Control Group

    In this study, the control group will receive standard care.

Interventions

  • OtherCare based on Kolcaba's comfort theory

    During the application process, the babies in the experimental group will receive care based on Kolcaba's comfort theory during their stay in intensive care.

    Also known as: Control Group

06

What researchers measure

Primary outcomes

  1. Neonatal Infant Pain Scale-Nips

    The scale developed by Lawrence et al. is used for premature and newborns. In the neonatal pain scale, 5 (five) behavioral groupings (facial expression, crying, movements of arms and legs, state of wakefulness) and a physiological parameter (respiratory pattern) are evaluated and measured. Total score varies between 0-7. A high score on this scale indicates that the intensity of the pain is high. .

    Time frame: It will be filled at the 0th hour of admission and then at the 24th, 48th and 72nd hour.

  2. Newborn Comfort Behavior Scale

    It is a Likert-type scale consisting of six parameters: alertness, calmness/agitation, respiratory response, crying, body movements, facial tension, and muscle tone. M. Each item in the scale is scored from 1 to 5. It is evaluated based on the total score. The lowest score that can be obtained from the Newborn Comfort Behavior Scale (YKDS) is 6 and the highest score is 30. If the total score of the scale is between 14-30, it is emphasized that the baby is in pain or distress, is uncomfortable and needs interventions to provide comfort. Scoring 4-6 on the Numerical Rating Scales indicates moderate pain and distress, while scoring 7-10 indicates severe pain and distress.

    Time frame: It will be filled at the 0th hour of admission and then at the 24th, 48th and 72nd hour.

07

Study locations

1 site
  • Tatvan Devlet Hastanesi
    Bitlis, tATATVAN/BİTLİS 13200, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06491641
Lead sponsor
Cukurova University
Responsible party
Fahri AŞKAN (Assistant Professor, Cukurova University) — Principal investigator
First posted
Jul 9, 2024
Start date
Jul 26, 2024
Primary completion
Jul 2, 2025
Completion
Jul 2, 2025
Last update
Jul 29, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion